← Surfer · The Kit · Coach hub
Coach — Broccoli Sprouts (timed electrophile pulse)
Three-day broccoli sprouts are not a superfood in the usual sense. In the hypothesis behind this essay, they deliver a brief chemical alarm that switches on the cell's own defense program, and the timing of that alarm matters as much as the dose.
Safety first
A food can still carry cautions, and the extended report lists them directly. "People with active cancer, especially KEAP1- or NFE2L2-altered tumors, should not treat Nrf2 activation as benign. Sulforaphane can inhibit CYP enzymes and may alter drug handling. Iodine deficiency with goiter risk, anticoagulation, and pregnancy are separate reasons to clear a crucifer load with a clinician. N-acetylcysteine has its own indications and adverse effects and is not interchangeable with food." It adds: "Food-level sprout use in healthy adults has looked well tolerated in short trials. That is not a safety claim for chronic high intake."
Those cautions mean something concrete. Anyone with active cancer, anyone taking medicines whose levels depend on liver enzymes, and anyone with thyroid concerns, on a blood thinner, or pregnant should talk with a physician before eating sprouts in quantity. And this essay does not say N-acetylcysteine is harmful in its clinical uses. Anyone taking it on a physician's direction keeps that decision with the prescriber.
A signal, not a fuel
The hypothesis is compact. A small raw serving of three-day broccoli sprouts, eaten on repair days only, raises a short-lived defense program that supports the mitochondrial engine without occupying the part of the week reserved for growth. The molecule is cleared within a day. The enzyme program it switches on lasts one to two days and is allowed to fall before the next growth meal. The sprout is a signal, not a fuel. Food, light, and resistance training still do the work a vegetable cannot.
Why sprouts, and why raw
Three-day sprouts carry both halves of a chemical reaction. They concentrate glucoraphanin, a stable and inactive compound, far above mature broccoli, and they still carry myrosinase, the plant enzyme that converts it, provided they are not cooked. Chewing brings the two together and releases sulforaphane, the reactive molecule that is the actual signal.
Heat kills the sprout's enzyme. When a crucifer has been cooked, the report notes that brown mustard powder or raw daikon added afterward restores the enzyme the heat destroyed. Without the plant enzyme, conversion falls to gut bacteria, which do it variably, often poorly, and sometimes hardly at all after antibiotics. A glucoraphanin capsule taken without an enzyme is the same lottery; the report calls it, at best, a weaker travel spare of the idea, and only with an active enzyme eaten alongside.
Amounts are information here, not instruction. The report describes a practical food serving in the range discussed in clinical work as about 20 to 40 grams of fresh sprouts, chewed until the bite is hot, and notes that a couple of ounces of sprouts can match a large serving of market broccoli. Content is not standardized. Glucoraphanin varies several-fold with seed, age, and storage. The internal dose is what shows up as sulforaphane metabolites in urine, not what the label or the scale says.
The defense program
Sulforaphane works by looking, briefly, like a toxin. Inside the cell, a sensor protein called Keap1 normally binds a defense regulator called Nrf2 and sends it for destruction, so under quiet conditions Nrf2 barely exists. Sulforaphane modifies reactive sites on Keap1. Nrf2 escapes, enters the nucleus, and switches on a set of genes. What it induces is capacity rather than scavenging: enzymes that detoxify reactive compounds, the enzymes that make glutathione, the cell's main internal antioxidant, and several enzymes that regenerate NADPH, the reducing power the cell needs to keep its defenses charged. A molecule that is itself an antioxidant does not open this system. A molecule that looks briefly dangerous does.
The report places the pulse on the repair side of the cell's weather. Nrf2 competes with, and indirectly restrains, a major inflammatory switch, a tilt rather than a shutdown. The same program raises glutathione and NADPH, which the energy chain depends on, and feeds forward into the machinery that builds mitochondria. In muscle-cell models a single pulse shows Nrf2 in the nucleus within hours and higher respiration a day later. It is not a dedicated mitochondrial-cleanup signal, and it is not an energy-sensor drug, though the two systems talk to each other.
There is a reason not to push harder. Nrf2 has two faces. Switched on briefly, it protects intact tissue. Switched on permanently, by mutations that disable Keap1 or overactivate Nrf2, it can help tumors grow, rewire their metabolism, and resist therapy. That is why the cancer caution opens this essay, and why the hypothesis depends on a pulse that is allowed to clear.
Molecule versus program
The timing follows from the pharmacology. Sulforaphane peaks in blood about an hour to an hour and a half after a serving with active enzyme, has a half-life of about two hours, and is essentially finished being excreted by 24 hours. What lingers is transcription. A brief pulse raises the defense genes' messages for about 12 to 24 hours, and the proteins themselves can stay elevated beyond 48 hours in cell models. Repeated servings accumulate the enzymes, not the molecule. Nothing eaten late in one week is still circulating at the start of the next; at most it leaves a fading defense tail.
The clock matters too. Nrf2 levels follow the daily clock and rise in the active phase, late morning to early afternoon in people who are awake by day. Because sulforaphane peaks one to two hours after a meal, the hypothesis places the serving early in the day, after morning light and inside the eating window. An evening serving would put an activity-phase alarm into the window the body reserves for sleep.
The week matters last. Human trials that changed detoxifying enzymes, pollutant excretion, or bowel habit used repeated daily exposure, including about 20 grams of sprouts a day for several weeks, not a weekly hit. In the hypothesis, the one exception is the growth day of a training week, the day built around a hard session and a protein-rich meal. Keeping the sprouts off that day avoids stacking an energy-sensor-leaning signal on the growth signal. The report is clear that this is pathway hygiene, not a pharmacokinetic requirement, because the molecule would be gone either way. The training week itself is explained in the extended report on strength.
N-acetylcysteine is not the same pathway
N-acetylcysteine, usually called NAC, and sulforaphane meet at glutathione but enter from opposite directions. NAC supplies the raw material: it is converted to cysteine, the building block that limits how fast glutathione can be made. It is also a reducing agent, which is why it thins mucus. The sprout does something different. It never donates cysteine. It builds the factory, raising the enzymes that make and use glutathione. An ordinary protein-rich meal already stocks that factory with cysteine and methionine. The differences run through the whole comparison. The sprout is tied to the daily clock and to the repair side of the week; NAC is neither. The sprout shares the hormetic pulse of training; NAC can buffer it. The sprout leaves a program behind after the molecule is gone; NAC leaves substrate, not a program.
The two can collide around training. A hard session works by the same logic as the sprout: reactive molecules modify Keap1, Nrf2 rises, and the defense set is written. High-dose antioxidants taken around the session can consume that signal before it is read, and a standing daily reductant can flatten both the training and the sprout signal. The report's conclusion is narrow: with adequate protein and sprouts, a standing NAC habit may be redundant beside this pulse, and across a training block its adaptive effect is unsettled. It also draws the boundary clearly: "Keep NAC for a defined job: mucus, an acetaminophen exposure, a clinician-directed course."
What would count against it
The hypothesis names its own failure signals. No rise in urinary sulforaphane metabolites after a chewed serving means conversion failed. No change in a defense-enzyme marker across the repair days means the pulse is too small. Worse recovery, sleep, or training quality on sprout days means the amount has left the helpful range. And a clear benefit from adding daily NAC on top of protein and sprouts would challenge the claim that it is redundant.
What the hypothesis does not claim matters as much. It does not claim that sprouts treat, prevent, or reverse disease, or that a handful delivers a standardized amount of sulforaphane. It does not claim that a glucoraphanin capsule without the plant enzyme reproduces the food, and it does not claim that NAC is harmful in its clinical uses, only that it is the wrong standing input beside this pulse. Nothing here replaces the basics discussed under fuel. The neighboring essay on rapamycin describes the larger growth-and-repair rhythm this signal is meant to sit inside.
For the full argument, read the extended report on broccoli sprouts. The short version is in the lessons. Talk with your own physician before changing medications or supplements.
A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 17, 2026.
See the notice at the top of this page. Working hypothesis, not medical advice and not a dosing recommendation. Not a self-treatment guide. Active cancer (especially KEAP1- or NFE2L2-altered tumors), drug handling through CYP enzymes, iodine deficiency with goiter risk, anticoagulation, and pregnancy are reasons to clear a crucifer load with a clinician. NAC has its own clinical uses.